Crowdfunding campaign for research on novel Parkinson’s and Alzheimer’s therapies

My brother is doing a crowdfunding campaign to raise money for research on novel Parkinson’s and Alzheimer’s therapies. Please watch his introduction and please support this important cause (if you are able to). Or share it. Thank you.

https://www.indiegogo.com/project/novel-parkinson-s-alzheimer-s-therapies/embedded

He is the founder and owner of Gardedam Therapeutics, an early-stage biotechnology company engaged in cutting-edge research and therapy development for neurodegenerative diseases.

Gardedam Therapeutics is a privately held, preclinical stage start-up biotechnology company founded by Gergely Tóth, Ph.D., MBA in Palo Alto, California (USA) in 2009. Gardedam Therapeutics has operations in the USA, Hong Kong and Colombia. The launch of the company was enabled by support from and partnership with Graffinity Pharmaceuticals (now Novalix) and C. Rochet, Ph.D. at Purdue University. In 2010 and 2013, in collaboration with C. Rochet Ph.D., the company was awarded two distinct grants by the Michael J. Fox Foundation for a total of US $150,000 in support of the DJ-1 therapeutic project.

https://www.facebook.com/GardedamTherapeutics

Advertisements

One thought on “Crowdfunding campaign for research on novel Parkinson’s and Alzheimer’s therapies

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s